Low CD34+ and CD34+CD133+ cell levels significantly and independently predicted the development or worsening of microangiopathy in diabetic patients22 and a reduced CD34+ and CD34+CD133+ cell count independently predicted future events in patients with type 2 diabetes.23 This evidence concerns the gene PROM1 and type 2 diabetes mellitus.